Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

13:38 ET Study reveals barriers to obtaining overdose-reversing drug naloxone in pharmacies, especially for teens

A study conducted through The Feinstein Institutes for Medical Research and led by Andrew Adesman, MD, chief of developmental and behavioral...


13:11 ET Elkem Expands Implantable Silicone Offering Introducing New Heat Cured Rubber Product Line

Elkem announces it has expanded its long-term implantable silicone offering with the introduction of Silbione® Biomedical HCRA M500 series, a new...


12:47 ET Researchers Explore How to End the Opioid Crisis at Web Event Tomorrow

While major drug companies reached a $260 million settlement to avert a federal opioid trial this week, the crisis continues to impact Americans....


12:18 ET SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Eloxx Pharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...


12:01 ET Duke Clinical Research Institute to Lead Pragmatic Study to Assess Effectiveness of Statins in Older Adults

Building on its success in leading pragmatic approaches for clinical study design, the Duke Clinical Research Institute (DCRI), part of the Duke...


12:00 ET CVS Health Expands Safe Medication Disposal Program in Wisconsin, Giving Customers Drug Disposal Options in All CVS Pharmacy Locations

In its continuing commitment to help build healthier communities, CVS Health (NYSE: CVS) today announced the expansion of its safe medication...


10:45 ET HKBU Drug the First in Hong Kong to be Granted Orphan Drug Designation by the US FDA

A research team from the School of Chinese Medicine at Hong Kong Baptist University (HKBU) has successfully developed a novel aptamer, i.e. a...


10:24 ET Trifecta Clinical Expands Management Team

Clinical technology and process automation provider, Trifecta Clinical, today announced the expansion of its senior management team. In response to...


10:00 ET BlueWillow Receives FDA Clearance to Begin Phase 1 Study of its Intranasal Anthrax Vaccine

BlueWillow Biologics®, a clinical-stage biopharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) has cleared its...


09:00 ET At CNS Summit 2019, Signant Health to Host Spotlight Session Including Speakers from Karuna and Avanir to Discuss the Future of eCOA and Data Analytics to Improve the Patient Experience in Clinical Research

Each year, the CNS Summit convenes many of the foremost innovators and thought leaders focused on advancing the patient experience in clinical...


09:00 ET Zyla Life Sciences Announces Management Changes

Zyla Life Sciences (OTCQX: ZCOR) ("Zyla"), a commercial-stage life sciences company, today announced that Robert Radie, has resigned as president,...


08:36 ET NeuroRx Secures HK$ 750 Million Capital Commitment From The Gem Group for Development of NRX-101

NeuroRx, Inc (NeuroRx) announced that it has signed an agreement with GEM Global Yield LLC SCS ("GEM"), the New York based private alternative...


08:01 ET Jennifer Chao Appointed Chairperson of BioSpecifics Technologies Corp. Board of Directors

BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with ...


08:00 ET Insmed to Host Third Quarter 2019 Financial Results Conference Call on Wednesday, October 30, 2019

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...


08:00 ET Ambrx and NovoCodex form Second Collaboration to Develop and Commercialize Ambrx's Antibody Drug Conjugates

Ambrx and NovoCodex Biopharmaceuticals Ltd., (NovoCodex), a majority owned company of Zhejiang Medicine Co Ltd., today announced that they have...


07:30 ET Rigel Pharmaceuticals Provides Business Update Prior to Investor & Analyst Call

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today provided a business update that will be discussed in more detail on the company's investor and...


07:30 ET Allergan Presents Data From Eleven Abstracts At The 2019 American Society for Dermatologic Surgery (ASDS) in Chicago

Allergan plc (NYSE: AGN) today announced that its data will be featured during the 2019 American Society for Dermatologic Surgery Annual Meeting in...


07:30 ET ImpediMed Announces Ambitious New Program Aimed at Ending Cancer-Related Lymphedema

ImpediMed Limited (ASX: IPD), a global provider of medical technology to non-invasively measure, monitor and manage tissue composition and fluid...


07:00 ET Biomica to Collaborate With Weizmann Institute of Science to Develop a Selective Treatment Against Antibiotic Resistant Bacteria

Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN)...


07:00 ET Ceramic Hip Prosthesis Market to Reach USD 3,424.5 Million by 2026 | Reports and Data

Ceramic Hip Prosthesis Market Size – USD 2,012 million in 2018, Market Growth - CAGR of 6.7%, Ceramic Hip Prosthesis Industry Trends – Increase in...


07:00 ET Alkermes Plc Reports Third Quarter 2019 Financial Results and Implementation of Restructuring

Alkermes plc (Nasdaq: ALKS) today reported financial results for the third quarter of 2019 and the implementation of a restructuring plan following a ...


06:25 ET Lilly Reports Strong Third-Quarter 2019 Financial Results, Raises 2019 EPS Guidance

Eli Lilly and Company (NYSE: LLY) today announced financial results for the third quarter of 2019. $ in millions, except per share data Third Quarter ...


06:00 ET United Therapeutics Corporation to Report Third Quarter 2019 Financial Results Before the Market Opens on Wednesday, October 30, 2019

United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its third quarter 2019 financial results before the market opens...


06:00 ET Enrique Conterno, Senior Vice President and President of Lilly Diabetes and Lilly USA, to Retire at End of Year; Mike Mason to Succeed Conterno

Eli Lilly and Company (NYSE: LLY) announced today that Enrique Conterno, senior vice president of Lilly and president of Lilly Diabetes and Lilly...